Review of neonatal alloimmune thrombocytopenia

Journal of Paediatrics and Child Health

Volumn 48, Issue 9, 2012, Pages 816-822

  Risson, David C ^a,b   Davies, Mark W ^a,b   Williams, Bronwyn A ^c,d  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND HEALTH   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

human platelet antigens; neonatal alloimmune thrombocytopenia; neonatal thrombocytopenia

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; IMMUNOGLOBULIN; MATERNAL ANTIBODY; THROMBOCYTE ANTIGEN;

BLOOD GROUP ABO INCOMPATIBILITY; BLOOD SAMPLING; BRAIN HEMORRHAGE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FETOMATERNAL TRANSFUSION; FETUS BLOOD; GENE FREQUENCY; HEMODILUTION; HIGH RISK PREGNANCY; HUMAN; IMMUNOPHENOTYPING; LIVE BIRTH; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

HUMANS; INFANT, NEWBORN; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84866234238     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2012.02528.x     Document Type: Review

References (51)

1. Metcalfe P, Watkins NA, Ouwehand WH, et al,. Nomenclature of human platelet antigens. Vox. Sang. 2003; 85: 240-5. Epub 2003/10/01.
2. Kaplan C,. The role of low frequency antigens in neonatal alloimmune thrombocytopenia. ISBT Sci. Ser. 2007; 2: 106-10.
3. Davoren A, Curtis BR, Aster RH, McFarland JG,. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44: 1220-5. Epub 2004/07/22.
4. Ghevaert C, Campbell K, Walton J, et al,. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007; 47: 901-10. Epub 2007/05/01.
5. Kaplan C, Porcelijn L, Vanlieferinghen P, et al,. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Transfusion 2005; 45: 1799-803.
6. Arnold DM, Smith JW, Kelton JG,. Diagnosis and management of neonatal alloimmune thrombocytopenia. Transfus. Med. Rev. 2008; 22: 255-67. Epub 2008/10/14.
7. Bennett JA, Palmer LJ, Musk AW, Erber WN,. Gene frequencies of human platelet antigens 1-5 in indigenous Australians in Western Australia. Transfus. Med. 2002; 12: 199-203. Epub 2002/06/20.
8. Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J,. Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program. Scand. J. Immunol. 2009; 70: 531-4. Epub 2009/11/13.
9. Williamson LM, Hackett G, Rennie J, et al,. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92: 2280-7. Epub 1998/09/25.
10. Mueller-Eckhardt C, Kiefel V, Grubert A, et al,. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1: 363-6. Epub 1989/02/18.
11. Blanchette VS, Chen L, de Friedberg ZS, Hogan VA, Trudel E, Decary F,. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br. J. Haematol. 1990; 74: 209-15. Epub 1990/02/01.
12. Anani Sarab G, Moss M, Barker RN, Urbaniak SJ,. Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB30101-positive antigen-presenting cells. Blood 2009; 114: 1954-7. Epub 2009/06/06.
13. Kjeldsen-Kragh J, Killie MK, Tomter G, et al,. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110: 833-9. Epub 2007/04/13.
14. Chen P, Li C, Lang S, et al,. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood 2010; 116: 3660-8. Epub 2010/07/22.
15. Kaplan C,. FNAIT: the fetus pleads guilty! Blood 2010; 116: 3384-6. Epub 2010/11/06.
16. Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B,. The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes. Clin. Dev. Immunol. 2012; 2012: 1-5. Epub 2011/11/24.
17. Baer VL, Lambert DK, Henry E, Christensen RD,. Severe thrombocytopenia in the NICU. Pediatrics 2009; 124: e1095-100. Epub 2009/11/18.
18. Geddis AE,. A POTEntial new gene for thrombocytopenia. Blood 2011; 117: 6406-8.
19. de Moerloose P, Boehlen F, Extermann P, Hohfeld P,. Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay. Br. J. Haematol. 1998; 100: 735-40. Epub 1998/04/08.
20. Roberts I, Stanworth S, Murray NA,. Thrombocytopenia in the neonate. Blood Rev. 2008; 22: 173-86. Epub 2008/04/25.
21. Bussel J,. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J. Thromb. Haemost. 2009; 7 (Suppl. 1): 253-7. Epub 2009/07/28.
22. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C,. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr. Blood Cancer 2005; 45: 176-83. Epub 2005/04/14.
23. Sainio S, Jarvenpaa AL, Renlund M, Riikonen S, Teramo K, Kekomaki R,. Thrombocytopenia in term infants: a population-based study. Obstet. Gynecol. 2000; 95: 441-6. Epub 2000/03/11.
24. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G,. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood 1997; 89: 4402-6. Epub 1997/06/15.
25. Dawkins B,. Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test. Vox. Sang. 1995; 68: 27-34. Epub 1995/01/01.
26. (QLD) ARCBS. Platelet Immunology Reference Laboratory Manual. 2009.
27. Radder CM, Brand A, Kanhai HH,. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox. Sang. 2003; 84: 318-25. Epub 2003/05/22.
28. Spencer JA, Burrows RF,. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust. N. Z. J. Obstet. Gynaecol. 2001; 41: 45-55. Epub 2001/04/04.
29. Ackerman B, Rouse GA, de Lange M, Bedros AA, Sakala EP,. The sonographic detection of intracranial hemorrhage due to alloimmune thrombocytopenia. J. Diagn. Med. Sonography 1992; 8: 249-55.
30. Dale ST, Coleman LT,. Neonatal alloimmune thrombocytopenia: antenatal and postnatal imaging findings in the pediatric brain. AJNR Am. J. Neuroradiol. 2002; 23: 1457-65. Epub 2002/10/10.
31. Mohila CA, Kubicka ZJ, Ornvold KT, Harris BT,. Cerebellar loss and brain-stem atrophy associated with neonatal alloimmune thrombocytopenia in a discordant twin. Pediatr. Dev. Pathol. 2010; 13: 55-62. Epub 2009/07/11.
32. Kaplan C, Morel-Kopp MC, Kroll H, et al,. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br. J. Haematol. 1991; 78: 425-9. Epub 1991/07/01.
33. Rousseau J, Goldman M, David M,. HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases. Transfusion 2004; 44: 844-8. Epub 2004/05/26.
34. van Gils JM, Stutterheim J, van Duijn TJ, et al,. HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity. Mol. Immunol. 2009; 46: 406-15. Epub 2008/11/29.
35. Kiefel V, Bassler D, Kroll H, et al,. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 2006; 107: 3761-3. Epub 2006/01/13.
36. Blanchette VS, Johnson J, Rand M,. The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract. Res. Clin. Haematol. 2000; 13: 365-90. Epub 2000/10/13.
37. Josephson CD, Su LL, Christensen RD, et al,. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123: 278-85. Epub 2009/01/02.
38. Wu Y, Stack G,. Blood product replacement in the perinatal period. Semin. Perinatol. 2007; 31: 262-71. Epub 2007/09/11.
39. Kamphuis MM, Oepkes D,. Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat. Diagn. 2011; 31: 712-9. Epub 2011/05/28.
40. Gibson BE, Todd A, Roberts I, et al,. Transfusion guidelines for neonates and older children. Br. J. Haematol. 2004; 124: 433-53. Epub 2004/02/27.
41. Anderson D, Ali K, Blanchette V, et al,. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus. Med. Rev. 2007; 21: S9-56.
42. Sidiropoulos D, Straume B,. The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.). Ann. Hematol. 1984; 48: 383-6.
43. Allen D, Verjee S, Rees S, Murphy MF, Roberts DJ,. Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood 2007; 109: 388-9. Epub 2006/12/28.
44. Bessos H, Killie MK, Seghatchian J, Skogen B, Urbaniak SJ,. The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia-where does it stand? Transfus. Apher. Sci. 2009; 40: 75-8. Epub 2009/02/19.
45. Davoren A, McParland P, Barnes CA, Murphy WG,. Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases. J. Clin. Pathol. 2002; 55: 289-92.
46. Tiller H, Killie MK, Skogen B, Oian P, Husebekk A,. Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme. BJOG 2009; 116: 594-8. Epub 2009/03/03.
47. Allen D, Knight M, Spark P, Roberts DJ, Murphy MF,. Fetomaternal alloimmune thrombocytopenia (FMAIT) in the UK: a prospective national study of incidence and outcomes using obstetric, paediatric and laboratory reporting systems (abstract 22). Br. J. Haematol. 2010; 149 (Suppl. 1): 1-96.
48. Bertrand G, Drame M, Martageix C, Kaplan C,. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia. Blood 2011; 117: 3209-13.
49. Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF,. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst. Rev. 2011; 5: CD004226. Epub 2011/05/13.
50. Bussel JB, Berkowitz RL, Hung C, et al,. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am. J. Obstet. Gynecol. 2010; 203: 135 e1-14. Epub 2010/05/25.
51. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B,. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008; 93: 870-7. Epub 2008/04/30.